{
     "PMID": "26764241",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170613",
     "LR": "20171205",
     "IS": "1873-7064 (Electronic) 0028-3908 (Linking)",
     "VI": "105",
     "DP": "2016 Jun",
     "TI": "Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.",
     "PG": "142-153",
     "LID": "S0028-3908(15)30218-5 [pii] 10.1016/j.neuropharm.2015.12.022 [doi]",
     "AB": "Pharmacological studies have yielded valuable insights into the role of the serotonin 2A (5-HT2A) receptor in major depressive disorder (MDD) and antidepressant drugs (ADs) response. However, it is still unknown whether genetic variants in the HTR2A gene affect the therapeutic outcome of ADs and the mechanism underlying the regulation of such response remains poorly described. In this context, a translational human-mouse study offers a unique opportunity to address the possibility that variations in the HTR2A gene may represent a relevant marker to predict the efficacy of ADs. In a first part of this study, we investigated in depressed patients the effect of three HTR2A single nucleotide polymorphisms (SNPs), selected for their potential functional consequences on 5-HT2A receptor (rs6313, rs6314 and rs7333412), on response and remission rates after 3 months of antidepressant treatments. We also explored the consequences of the constitutive genetic inactivation of the 5-HT2A receptor (i.e. in 5-HT2A(-/-) mice) on the activity of acute and prolonged administration of SSRIs. Our clinical data indicate that GG patients for the rs7333412 SNP were less prone to respond to ADs than AA/AG patients. In the preclinical study, we demonstrated that the 5-HT2A receptor exerts an inhibitory influence on the neuronal activity of the serotonergic system after acute administration of SSRIs. However, while the chronic administration of the SSRIs escitalopram or fluoxetine elicited a progressive increased in the firing rate of 5-HT neurons in 5-HT2A(+/+) mice, it failed to do so in 5-HT2A(-/-) mutants. These electrophysiological impairments were associated with a decreased ability of the chronic administration of fluoxetine to stimulate hippocampal plasticity and to produce antidepressant-like activities. Genetic loss of the 5-HT2A receptor compromised the activity of chronic treatment with SSRIs, making this receptor a putative marker to predict ADs response.",
     "CI": [
          "Copyright (c) 2015 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Qesseveur, Gael",
          "Petit, Anne Cecile",
          "Nguyen, Hai Thanh",
          "Dahan, Lionel",
          "Colle, Romain",
          "Rotenberg, Samuel",
          "Seif, Isabelle",
          "Robert, Pauline",
          "David, Denis",
          "Guilloux, Jean-Philippe",
          "Gardier, Alain M",
          "Verstuyft, Celine",
          "Becquemont, Laurent",
          "Corruble, Emmanuelle",
          "Guiard, Bruno P"
     ],
     "AU": [
          "Qesseveur G",
          "Petit AC",
          "Nguyen HT",
          "Dahan L",
          "Colle R",
          "Rotenberg S",
          "Seif I",
          "Robert P",
          "David D",
          "Guilloux JP",
          "Gardier AM",
          "Verstuyft C",
          "Becquemont L",
          "Corruble E",
          "Guiard BP"
     ],
     "AD": "Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, Fac Pharmacie, Chatenay Malabry, 92290, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, CESP, Fac Medecine Paris Sud, 94275, Le Kremlin Bicetre, France; Assistance Publique-Hopitaux de Paris, Hopitaux Universitaires Paris-Sud, Hopital de Bicetre, Service de Psychiatrie, Le Kremlin Bicetre, F-94275, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, Fac Pharmacie, Chatenay Malabry, 92290, France. Centre de Recherches sur la Cognition Animale, Centre de Biologie Integrative, Universite de Toulouse, CNRS, UPS, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, CESP, Fac Medecine Paris Sud, 94275, Le Kremlin Bicetre, France; Assistance Publique-Hopitaux de Paris, Hopitaux Universitaires Paris-Sud, Hopital de Bicetre, Service de Psychiatrie, Le Kremlin Bicetre, F-94275, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, CESP, Fac Medecine Paris Sud, 94275, Le Kremlin Bicetre, France; Assistance Publique-Hopitaux de Paris, Hopitaux Universitaires Paris-Sud, Hopital de Bicetre, Service de Psychiatrie, Le Kremlin Bicetre, F-94275, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, Fac Pharmacie, Chatenay Malabry, 92290, France. UMS IPSIT (INST. Paris-Saclay d'innovation Therapeutique), Paris Sud, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, Fac Pharmacie, Chatenay Malabry, 92290, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, Fac Pharmacie, Chatenay Malabry, 92290, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, Fac Pharmacie, Chatenay Malabry, 92290, France. INSERM U1184, Le Kremlin Bicetre, F-94276, France; Assistance Publique-Hopitaux de Paris, Hopitaux Universitaires Paris-Sud, Hopital de Bicetre, Service de Genetique moleculaire, Pharmacogenetique et Hormonologie, Le Kremlin Bicetre, F-94275, France. INSERM U1184, Le Kremlin Bicetre, F-94276, France; Assistance Publique-Hopitaux de Paris, Hopitaux Universitaires Paris-Sud, Hopital de Bicetre, Service de Genetique moleculaire, Pharmacogenetique et Hormonologie, Le Kremlin Bicetre, F-94275, France. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, CESP, Fac Medecine Paris Sud, 94275, Le Kremlin Bicetre, France; Assistance Publique-Hopitaux de Paris, Hopitaux Universitaires Paris-Sud, Hopital de Bicetre, Service de Psychiatrie, Le Kremlin Bicetre, F-94275, France. Electronic address: emmanuelle.corruble@bct.aphp.fr. Universite Paris-Saclay, Univ. Paris-Sud, INSERM UMR-S 1178, Fac Pharmacie, Chatenay Malabry, 92290, France; Centre de Recherches sur la Cognition Animale, Centre de Biologie Integrative, Universite de Toulouse, CNRS, UPS, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20160104",
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Receptor, Serotonin, 5-HT2A)",
          "0 (Serotonin Uptake Inhibitors)",
          "01K63SUP8D (Fluoxetine)",
          "0DHU5B8D6V (Citalopram)"
     ],
     "SB": "IM",
     "MH": [
          "Adolescent",
          "Adult",
          "Aged",
          "Animals",
          "Antidepressive Agents/*therapeutic use",
          "Cell Survival/drug effects",
          "Citalopram/administration & dosage",
          "Depressive Disorder, Major/*drug therapy/*genetics",
          "Dorsal Raphe Nucleus/drug effects/physiology",
          "Fluoxetine/administration & dosage",
          "Genotype",
          "Hippocampus/drug effects/physiology",
          "Humans",
          "Mice",
          "Mice, Knockout",
          "Middle Aged",
          "Neurons/drug effects/physiology",
          "Polymorphism, Single Nucleotide",
          "Receptor, Serotonin, 5-HT2A/*genetics/*physiology",
          "Serotonin Uptake Inhibitors/*administration & dosage",
          "Translational Medical Research",
          "Young Adult"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*5-HT transporter",
          "*5-HT(1A) receptor",
          "*5-HT(2A) receptor",
          "*5-HT2A receptor",
          "*Antidepressant",
          "*Electrophysiology",
          "*Genetic",
          "*Hippocampus",
          "*MDD: major depressive disorder",
          "*MDE: major depressive episode",
          "*Polymorphism",
          "*SSRI"
     ],
     "EDAT": "2016/01/15 06:00",
     "MHDA": "2017/06/14 06:00",
     "CRDT": [
          "2016/01/15 06:00"
     ],
     "PHST": [
          "2015/09/25 00:00 [received]",
          "2015/12/23 00:00 [revised]",
          "2015/12/24 00:00 [accepted]",
          "2016/01/15 06:00 [entrez]",
          "2016/01/15 06:00 [pubmed]",
          "2017/06/14 06:00 [medline]"
     ],
     "AID": [
          "S0028-3908(15)30218-5 [pii]",
          "10.1016/j.neuropharm.2015.12.022 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 2016 Jun;105:142-153. doi: 10.1016/j.neuropharm.2015.12.022. Epub 2016 Jan 4.",
     "term": "hippocampus"
}